{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:57Z","timestamp":1791260637033,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["E-MTAB-16299"],"award-info":[{"award-number":["E-MTAB-16299"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019315","name":"Kansas City University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1R15CA287338"],"award-info":[{"award-number":["1R15CA287338"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dmd.2026.100250","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:04:53Z","timestamp":1770224693000},"page":"100250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential gene regulation by SR12813 and rifampicin: Insights into PXR and PPAR\u03b3 activation and metabolic pathway modulation in LS180 colon cancer cells"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-5225","authenticated-orcid":false,"given":"Dan","family":"Brobst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hemsath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbigail","family":"Niewchas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Lamboglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Bodily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Dye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff L.","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0822-3001","authenticated-orcid":false,"given":"Bradley A.","family":"Creamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5525","key":"10.1016\/j.dmd.2026.100250_bib1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity","volume":"292","author":"Watkins","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.dmd.2026.100250_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib3","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.54.6.1113","article-title":"Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element","volume":"54","author":"Schuetz","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100250_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.dmd.2026.100250_bib6","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1101\/gad.12.20.3195","article-title":"SXR, a novel steroid and xenobiotic-sensing nuclear receptor","volume":"12","author":"Blumberg","year":"1998","journal-title":"Genes Dev"},{"issue":"11","key":"10.1016\/j.dmd.2026.100250_bib7","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.3390\/cells10113262","article-title":"The interface between cell signaling pathways and pregnane X receptor","volume":"10","author":"Rogers","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.dmd.2026.100250_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.dmd.2026.100250_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/mp700103m","article-title":"Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response","volume":"5","author":"Moreau","year":"2008","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.dmd.2026.100250_bib10","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1124\/dmd.110.035568","article-title":"Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism","volume":"38","author":"Gao","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"13","key":"10.1016\/j.dmd.2026.100250_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.dmd.2026.100250_bib12","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/cells9102295","article-title":"Associations between pregnane X receptor and breast cancer growth and progression","volume":"9","author":"Creamer","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.dmd.2026.100250_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/cells13080681","article-title":"Pregnane X receptor signaling pathway and vitamin K: molecular mechanisms and clinical relevance in human health","volume":"13","author":"Staudinger","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.dmd.2026.100250_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.122.000858","article-title":"Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond","volume":"51","author":"Poudel","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2026.100250_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.dmd.2026.100250_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2796.2008.01951.x","article-title":"A gut feeling of the PXR, PPAR and NF-kappaB connection","volume":"263","author":"Wahli","year":"2008","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1042\/BST20110643","article-title":"PPARs and angiogenesis","volume":"39","author":"Bishop-Bailey","year":"2011","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"10.1016\/j.dmd.2026.100250_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12032-024-02363-z","article-title":"Dual function of activated PPAR\u03b3 by ligands on tumor growth and immunotherapy","volume":"41","author":"Chen","year":"2024","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100250_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389557521666210422112740","article-title":"Peroxisome proliferator-activated receptor-\u03b3 as a novel and promising target for treating cancer via regulation of inflammation: a brief review","volume":"22","author":"Yuvaraj","year":"2022","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"10.1016\/j.dmd.2026.100250_bib21","doi-asserted-by":"crossref","DOI":"10.1590\/s0102-865020200070000008","article-title":"PPARG expression in colorectal cancer and its association with staging and clinical evolution","volume":"35","author":"Villa","year":"2020","journal-title":"Acta Cir Bras"},{"issue":"10","key":"10.1016\/j.dmd.2026.100250_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2174\/1389200214666131211153307","article-title":"Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily","volume":"14","author":"Smutny","year":"2013","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJMra043590","article-title":"Retinoid x receptor heterodimers in the metabolic syndrome","volume":"353","author":"Shulman","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.dmd.2026.100250_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.119.264762","article-title":"Phosphorylation modulates the coregulatory protein exchange of the nuclear receptor pregnane X receptor","volume":"373","author":"Cui","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100250_bib25","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1172\/JCI41514","article-title":"Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dmd.2026.100250_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-4598-9-46","article-title":"Pregnane X receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation","volume":"9","author":"Raynal","year":"2010","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.dmd.2026.100250_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-017-0641-8","article-title":"Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer","volume":"16","author":"Dong","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.dmd.2026.100250_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/876418","article-title":"The role of peroxisome proliferator-activated receptors in colorectal cancer","volume":"2012","author":"Park","year":"2012","journal-title":"PPAR Res"},{"issue":"8","key":"10.1016\/j.dmd.2026.100250_bib29","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.dmd.2026.100250_bib30","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.dmd.2026.100250_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/jpet.103.064329","article-title":"Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor","volume":"310","author":"Brobst","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100250_bib32","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPARgamma through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:20:10Z","timestamp":1776147610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S009095562600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100250","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential gene regulation by SR12813 and rifampicin: Insights into PXR and PPAR\u03b3 activation and metabolic pathway modulation in LS180 colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100250"}}